|This is something I am looking into, it reads great and it may help, but I am unsure if the claims are valid and accurate... |
ALFLUTOP - antirheumatic products
ALFLUTOP? is a natural product with high efficacy therapeutical properties proved by tests and studies performed for over 18 years.
ALFLUTOP?, conditioned as injectable solution, contains in 1 ml solution 10 mg bioactive concentrate (amino acids, low molecular mass Peptides, mucopolysaccharides, trace elements: Na, K, Ca, Mg, Fe, Cu, Zn), maximum 5 mg/ml phenol as preservative.
ALFLUTOP? belongs to the group of chondroprotective products having anti-hyaluronidase, antiinflammatory and analgesic action:
inhibits hyaluronidase excess;
restores chondrocytes homeostasis in damaged tissues;
stimulates regenerative processes at cartilage level;
improves the synovial fluid and the afflicted cartilage quality;
stimulates superoxide diase;
inhibits occurrence of superoxide free radicals.
The clinical trials have proved the efficacy of the product ALFLUTOP? in degenerative articular rheumatism, post-traumatic pathology and abarticular rheumatism.
lack of major complications;
very well tolerated, even by the patients suffering from gastrointestinal, cardiovascular and metabolic diseases;
a favourable ratio of costs and clinical efficacy.
The clinical trials have also showed the therapeutical effect of ALFLUTOP? in the treatment of periarthritis, spondiloarthrosis, spinal disc injuries, ankylopoietic spondilitis, Reiter syndrome, rheumatoid polyarthritis.
Clinical Medicine №6 2004
Svetlova M. S., Ignatyev V. K.
Use of alflutop in the treatment of patients with osteoarthrosis
The efficiency of alflutop was studied in patients with osteoarthrosis (OA) of the knee or hip joints. The examinees (n = 24) received alflutop only intramuscularly (in coxarthrosis) or intramuscularly in combination with the intraarticular injection of the agent (in knee osteoarthrosis). Physical examinations were made in control periods: before and immediately, 3, 6, and 12 months after treatment. Arthrosonography was used as an objective method for controlling the efficacy of the drug. The studies have demonstrated that alflutop substantially relieves pain, improves the function of the diseased joints in patients with OA. Arthrosonography has shown that the drug exerts an antiinflammatory effect, retards the progression of a pathological process in the joint. Alflutop has been found to be more effective in knee OA than in hip OA, which is determined by that its combined use regimen may be used in knee OA. The necessity and high efficiency of repeated courses of alflutop therapy are shown.
The effects generally last from 6 to 9 months before the therapy must be repeated.
The amps are sterile water based and its very good tolerated by your body and no side effects.
Directions for use:
There are two methods for use: intramuscular (IM) & intra-articular (IA). IM injections are the easiest to deal with and allow the compound to absorb throughout your body to all necessary areas.
It has to be injected I.M.(intra muscular) 1 amp every day for 3 weeks (21 days), you can take again them after 2 months. Fore some, with more serious joint problems, a couple of rounds need to be done to bring the joints up to speed. (21 daily IM injections, 1 amp per injection, rotate inject sites)
The last clinical tests found that the amps can be injected 1-2 amps in affected parts of your articulation or damaged ligaments. This has to be done once at every 3 days during 3 weeks. It can be done again after 3 months. (THIS IS FOR ARTICULAR or DIRECT SITE INJECT THERAPY ONLY)